Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Cell and Gene Therapy
Precision base editing unlocks new potential for in vivo gene therapies.
May 21, 2025 -
3 min read
Cell and Gene Therapy
Revolutionizing cell therapies with base editing and AI-engineered CRISPR-Cas enzymes.
May 2, 2025 -
2 min read
Cell and Gene Therapy
Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.
April 2, 2025 -
3 min read
Cell and Gene Therapy
Cell and gene therapy gets on point with base editors.
February 19, 2025 -
6 min read
Cell and Gene Therapy
Base editing goes big: A role in functional pooled screening.
February 14, 2025 -
5 min read
Cell and Gene Therapy
Exploring the potential of base editing for sickle cell disease.
February 14, 2025 -
4 min read
Cell and Gene Therapy
Revvity supports Abata Therapeutics to impact the trajectory of autoimmune disease with engineered Treg cell therapies.
February 7, 2025 -
1 min read
Cell and Gene Therapy
BOOSTing lentiviral transduction for T cell therapy success.
October 7, 2024 -
3 min read
